Sniecinski Megan 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 17, 2020
Insider Transaction Report
Form 4
Sniecinski Megan
Chief Business Officer
Transactions
- Award
Emp. Stock Option (Right to Buy)
2020-12-15+225,000→ 225,000 totalExercise: $8.31From: 2021-12-15Exp: 2030-12-15→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.